Daehan New Pharm Co Ltd
KOSDAQ:054670
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
D
|
Daehan New Pharm Co Ltd
KOSDAQ:054670
|
93.1B KRW |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
987.9B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
596.5B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
293B CHF |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
249.7B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
240.5B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
307.4B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
156.9B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
Daehan New Pharm Co Ltd
Glance View
Daehan New Pharm Co., Ltd. engages in the production of pharmaceuticals and animal health goods. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2002-02-26. The firm provides two categories of products: human pharmaceutical products and animal pharmaceutical products. Its human pharmaceutical products include analgesics, anti-inflammatory drugs, antipyretics, antibacterial, antidiabetics, antihistamines, antineoplastics, immunosuppressants, cardiovascular drugs, gastrointestinal drugs, muscle relaxants, antispasmodics and others. Its animal pharmaceutical products include antibacterial, coccidiostats, antihelmintics, probiotic, nutrients, metabolic stimulants, disinfectants, functional supplement feeds, liver tonics, antihelmintics and others for poultries, cattle, sheep, swine and fishes.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Daehan New Pharm Co Ltd is 47%, which is above its 3-year median of 46.8%.
Over the last 3 years, Daehan New Pharm Co Ltd’s Gross Margin has decreased from 47.5% to 47%. During this period, it reached a low of 45% on Mar 31, 2023 and a high of 47.9% on Mar 31, 2025.
